Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q20707300> ?p ?o }
Showing triples 1 to 49 of
49
with 100 triples per page.
- Q20707300 subject Q8341873.
- Q20707300 subject Q8375173.
- Q20707300 subject Q8543773.
- Q20707300 abstract "ADB-CHMINACA (also known as MAB-CHMINACA) is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of Ki = 0.289 nM and was originally developed by Pfizer in 2009 as an analgesic medication. It was identified in cannabinoid blends in Japan in early 2015.".
- Q20707300 casNumber "1185887-13-1".
- Q20707300 fdaUniiCode "5BNC061EBB".
- Q20707300 iupacName "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide".
- Q20707300 pubchem "77565944".
- Q20707300 thumbnail ADB-CHMINACA_proper_structure.png?width=300.
- Q20707300 wikiPageWikiLink Q15708300.
- Q20707300 wikiPageWikiLink Q15708301.
- Q20707300 wikiPageWikiLink Q173235.
- Q20707300 wikiPageWikiLink Q18208892.
- Q20707300 wikiPageWikiLink Q18209025.
- Q20707300 wikiPageWikiLink Q19595738.
- Q20707300 wikiPageWikiLink Q206921.
- Q20707300 wikiPageWikiLink Q20706931.
- Q20707300 wikiPageWikiLink Q20706936.
- Q20707300 wikiPageWikiLink Q20706945.
- Q20707300 wikiPageWikiLink Q20707112.
- Q20707300 wikiPageWikiLink Q20707134.
- Q20707300 wikiPageWikiLink Q20707142.
- Q20707300 wikiPageWikiLink Q20707198.
- Q20707300 wikiPageWikiLink Q21098932.
- Q20707300 wikiPageWikiLink Q21163314.
- Q20707300 wikiPageWikiLink Q389934.
- Q20707300 wikiPageWikiLink Q417106.
- Q20707300 wikiPageWikiLink Q4391382.
- Q20707300 wikiPageWikiLink Q4650002.
- Q20707300 wikiPageWikiLink Q4650003.
- Q20707300 wikiPageWikiLink Q4653308.
- Q20707300 wikiPageWikiLink Q622899.
- Q20707300 wikiPageWikiLink Q6596473.
- Q20707300 wikiPageWikiLink Q8341873.
- Q20707300 wikiPageWikiLink Q8375173.
- Q20707300 wikiPageWikiLink Q8543773.
- Q20707300 wikiPageWikiLink Q928770.
- Q20707300 casNumber "1185887".
- Q20707300 iupacName "N--1--1H-indazole-3-carboxamide".
- Q20707300 pubchem "77565944".
- Q20707300 unii "5".
- Q20707300 type ChemicalSubstance.
- Q20707300 type Drug.
- Q20707300 type ChemicalObject.
- Q20707300 type Thing.
- Q20707300 type Q8386.
- Q20707300 comment "ADB-CHMINACA (also known as MAB-CHMINACA) is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of Ki = 0.289 nM and was originally developed by Pfizer in 2009 as an analgesic medication. It was identified in cannabinoid blends in Japan in early 2015.".
- Q20707300 label "ADB-CHMINACA".
- Q20707300 depiction ADB-CHMINACA_proper_structure.png.